Advert - Pierre Fabre

For briefing representatives about Toviaz (fesoterodine) using an uncertified presentation and failing to provide complete information, Pierre Fabre was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 9.1 - Failing to maintain high standards
Clause 14.1 - Failing to certify promotional material
Clause 15.9 - Producing representatives’ briefing material that did not comply with the relevant requirements of the Code

The Code of Practice Appeal Board publicly reprimanded Pierre Fabre for providing inaccurate information to the Panel.

Advert